Macroautophagy/autophagy can enable cancer cells to withstand cellular stress and maintain bioenergetic homeostasis by sequestering cellular components into newly formed double-membrane vesicles destined for lysosomal degradation, potentially affecting the efficacy of anti-cancer treatments. Using 13 C-labeled choline and 13 C-magnetic resonance spectroscopy and western blotting, we show increased de novo choline phospholipid (ChoPL) production and activation of PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), the rate-limiting enzyme of phosphatidylcholine (PtdCho) synthesis, during autophagy. We also discovered that the loss of PCYT1A activity results in compromised autophagosome formation and maintenance in autophagic cells. Direct tracing of ChoPLs with fluorescence and immunogold labeling imaging revealed the incorporation of newly synthesized ChoPLs into autophagosomal membranes, endoplasmic reticulum (ER) and mitochondria during anticancer drug-induced autophagy. Significant increase in the colocalization of fluorescence signals from the newly synthesized ChoPLs and mCherry-MAP1LC3/LC3 (microtubule-associated protein 1 light chain 3) was also found on autophagosomes accumulating in cells treated with autophagy-modulating compounds.
Introduction
Cytoprotective macroautophagy, henceforth referred to as autophagy, is implicated in resistance to a wide range of anticancer treatments by means of mitigating cellular stress [1, 2] inflicted by therapy-induced nutrient or growth factor deprivation, energy depletion, hypoxia, accumulation of protein aggregates, damage to organelles or DNA and reactive oxygen species production [3] . It is a highly regulated catabolic process, whereby parts of the cytosol and cellular organelles, including protein aggregates, damaged or superfluous organelles or pathogens, are sequestered into the double-membrane vesicles, called autophagosomes, and delivered to lysosomes for degradation. The resulting 'nutrients' are released into the cytosol to support energy metabolism, biosynthesis and cellular homeostasis. Here we investigate the metabolic impact of anti-cancer treatment, starvation and Tat-Beclin 1 induced autophagy in cancer cells.
Autophagy is initiated by the ULK1/2 (unc-51 like autophagy activating kinase 1/2) signaling as well as the activation of the PIK3C3/Vps34 (phosphatidylinositol 3-kinase catalytic subunit type 3) complex, containing BECN1/Beclin-1, which assembles at the phagophore nucleation site to produce phosphatidylinositol-3-phosphate (PtdIns3P) [4] .
For example, PtdIns3P contributes to the formation of an ER-associated cup-shaped membrane structure, the omegasome, which acts as a platform for the orchestrated recruitment of other autophagy proteins [5] . This leads to the phagophore expansion at least in part due to the lipidation, and hence membrane association, of the autophagosome marker LC3. The current consensus is that the autophagosome assembly takes place at the ER or, more specifically, ER-mitochondrial junctions during starvation-induced autophagy [5] [6] [7] [8] [9] [10] . Until the phagophore detaches from the ER, the phospholipids needed for its expansion are thought to be synthesized locally at the omegasome [11] . It is thought that subsequent autophagosome expansion is driven by vesicles derived from the Golgi and plasma membrane via recycling endosomes [11] [12] [13] . In the final stage the phagophore seals to form the autophagosome, which then fuses with the lysosome.
While the source of the autophagosomal membrane during starvation-induced autophagy has been subject to much recent research, the metabolism of major cellular phospholipids, PtdCho and PtdEth (phosphatidylethanolamine) is not well understood.
PtdEth has an established role in autophagy as the lipid anchor for LC3, which is required for the elongation of the phagophore and is thought to positively regulate the autophagic flux [14] [15] [16] .
The most abundant phospholipids in eukaryotic cell membranes are ChoPLs, which are essential for membrane structure and cellular function. Altered choline metabolism is a metabolic feature of oncogenesis and tumor progression [17] . ChoPLs comprise ester-or ether-linked PtdCho, sphingomyelin (SM) and ester-or ether-linked lysophosphatidylcholines (LysoPtdCho), with PtdChos accounting for more than 50%, SMs contributing a further 5-20%, and LysoPtdChos about 3% of all cellular membrane phospholipids [18, 19] . The Kennedy pathway accounts for the bulk of the ChoPL PtdCho biosynthesis (about 80% of all ChoPLs), with PCYT (choline phosphate cytidylyltransferase) being the rate-limiting enzyme and its predominant isoform being encoded by the PCYT1A gene ( Fig. 1A ) [20] . Some PtdChos can also be synthesized from LysoPtdCho by Lands cycle enzymes, LPCATs (lysophosphatidylcholine acyltransferases) [21] (Fig. 1A) . PtdCho can be used for downstream synthesis of LysoPtdCho and SMs.
The relative input of different organelles and the plasma membrane as well as de novo synthesis of phospholipids may vary depending on the initiating signal for autophagy and the nutrients available to the cells. Furthermore, replenishing phospholipid sources for autophagic membrane synthesis is required for their continual functioning and for ensuring autophagy-dependent survival during anti-cancer treatment. Consistently, neutral lipid stores were shown to contribute to autophagic membrane phospholipid formation during starvation-induced autophagy [22] .
Metabolic stress is a potent physiological stimulus of autophagy, with MTORC1
(mechanistic target of rapamycin kinase complex 1) being a major negative regulator of autophagy [23] . Starvation using a medium lacking amino acids and growth factors has been the system of choice for autophagy studies; however, it may not reflect the actual conditions found in the tumor microenvironment.
In this study, we examined choline phospholipid metabolism in cancer cells during autophagy under both nutrient-poor and nutrient-rich conditions. We used anticancer agents dichloroacetate (DCA), a pyruvate dehydrogenase kinase inhibitor currently in clinical investigation as antineoplastic treatment [24] that we had previously shown to induce autophagy [25] , and PI-103, a dual phosphoinositide 3-kinase (PI3K)-AKT (AKT serine/threonine kinase) and MTOR inhibitor that also induces cytoprotective autophagy in drug-resistant glioma and myeloma [26, 27] , to initiate autophagy in well-nourished conditions. We starved cells in Hanks Balanced Salt Solution (HBSS) to simulate nutrientpoor conditions. We had previously shown that DCA, PI-103 or starvation in HBSS induce autophagy in human colorectal carcinoma wild-type (WT) HCT116, HT29, and the apoptosis-resistant HCT116 BAX (BCL2 associated X, apoptosis regulator)-knockout (ko) cells, which is associated with MTORC1 inhibition [25, 28, 29] . We also treated HCT116 BAXko cells with Tat-Beclin 1, an autophagy-inducing peptide derived from BECN1, to induce autophagy independently of MTORC1 [30] .
With a novel approach to directly image newly synthesized ChoPLs, we showed their incorporation into autophagosomal membranes. We found increased expression of the rate-limiting enzyme of PtdCho synthesis, PCYT1A, in cancer cells undergoing autophagy and showed that the loss of its activity results in the inability of cells to maintain autophagosome biogenesis. Finally, using targeted mass spectrometry, we found that the increased level of choline phospholipids in autophagy was accompanied by an altered profile of choline phospholipid species.
Results

Cancer cells undergoing autophagy showed increase in choline phospholipids and decrease in phosphocholine levels.
Consistent with our previous findings [25, 28] , autophagy was induced in HCT116 WT, HCT116 BAX-ko and HT29 cells with DCA, PI-103 and starvation in HBSS as indicated by an elevated expression of the autophagy marker LC3B-II ( Fig. 1B) . Increased expression of LC3B-II with minimal apoptosis was also observed in Tat-Beclin 1-treated HCT116 BAX-ko cells, with no effect on MTORC1, as indicated by unchanged phosphorylation status of MTORC1 downstream effector RPS6 (ribosomal protein S6) when compared to Tat-Scramble control (Fig. 1C) .
Steady-state magnetic resonance spectroscopy ( 1 H-MRS) measurements ( Fig. S1A and B) revealed altered levels of intracellular choline metabolites in our autophagy models. The cellular level of phosphocholine (PCho) was reduced in all treatments ( Fig. 1D and Table S1 ). glycerophosphorylcholine (GPC) was reduced with 192 h of PI-103 treatment in HCT116 BAX-ko cells, increased with 24 h DCA treatment in both HCT116
BAX-ko and HCT116 WT cells but unchanged in the remaining autophagy models ( Fig. 1D and Table S1 ). Despite the reduced levels of PCho, ChoPLs were increased in all treatment groups ( Fig. 1D and Table S1 ). Our data suggested that autophagy in colorectal carcinoma cells was accompanied by alterations in the choline metabolic flux. We also measured the cellular levels of cholesterol, as it accounts for about 30% of total membrane lipids [31] . We observed an increase in total cholesterol in drug-treatment induced autophagy but not in Tat-Beclin 1 treatment or starvation models of autophagy ( Fig. 1D and Table S1 ), implying that an increase in ChoPLs might be a more universal marker of autophagy.
Increased choline phospholipid levels in cancer cells undergoing drug-induced
autophagy were due to de novo synthesis.
To establish whether the increased level of ChoPLs observed in autophagic cells under nutrient-rich conditions was due to an increase in the de novo synthesis, we traced [1,2-13 C]choline metabolites by 13 C-MRS ( Fig. S1C and D) . Autophagy was induced in HCT116 BAX-ko cells with 24 h PI-103 or DCA treatment, and in the last 6 h of the treatment the medium was substituted for that containing [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]choline instead of the unlabeled choline. The selection of this timing ensured that de novo ChoPL synthesis was measured after the onset of autophagy for both treatments (Fig. S2) . 13 C-labeled ChoPLs were increased in PI-103-treated and DCA-treated HCT116 BAX-ko cells when compared with controls ( Fig. 1E ). 13 C-labeled PCho was reduced following both treatments ( Fig. 1E) .
No 13 C-labeled GPC was detected during this time-course. These results indicated that de novo ChoPLs synthesis from choline was increased during drug-induced autophagy.
We next sought to understand the relationship between the levels of ChoPLs and LC3B-II since a positive correlation between LC3-II and the number of autophagosomes has been established [32, 33] . Linear regression analysis of the fold increase in cellular ChoPLs, as measured by MRS, versus the fold increase in LC3B-II, as measured by western blot, showed a significant (p=0.04) positive (R 2 =0.55) relationship between the two ( Fig. 1F) .
However, ChoPLs, and specifically the major PtdCho species, are intermediary metabolites involved in other metabolic processes as well. Thus, with DCA-induced autophagy, there was a large increase in the PtdCho breakdown product GPC, which was specific for the DCA treatment, but not in other autophagy models, suggesting that this effect was unrelated to autophagy ( Fig. 1D) . We observed a large increase in LC3B-II in DCA-treated cells, and indeed, our data from 13 C-choline tracing ( Fig. 1E ) indicated highly elevated de novo synthesis of ChoPLs. However, the steady-state level of ChoPLs ( Fig. 1D ) was increased to a much lesser extent, which might be a result of the net change in increased PtdCho synthesis and breakdown of PtdCho to GPC. We therefore used 13 C-choline tracing data for DCA treatment for Fig. 1F .
Newly synthesized choline phospholipids contributed to the phagophore membrane.
We next imaged the metabolic fate of the newly synthesized ChoPLs in cells undergoing autophagy to determine if they contribute to the newly synthesized membrane phospholipids in the forming and expanding phagophores, or replenish ChoPLs in other organelles, such as the ER and mitochondria, which supply membranes for the growing phagophores. We used propargylcholine (Pro-Cho), a synthetic analog of choline, which is converted via the Kennedy pathway to propargyl-PtdCho and all other classes of ChoPLs, albeit its incorporation into SM and ether PtdCho is somewhat slower [34] . Pro-Cho addition does not alter the relative abundance of other membrane phospholipids [34] .
Treatment media were supplemented with Pro-Cho at the start of the 6 h or 24 h treatment with PI-103 in HCT116 BAX-ko and HT29 cells, and in the last 6 h of 24 h DCA treatment of HCT116 BAX-ko cells, to account for the temporal differences in autophagy onset between DCA and PI-103 treatments ( Fig. S2) . Fluorescent Pro-ChoPL staining of the nuclear envelope and structures consistent with the ER and mitochondria was visible in both control and in PI-103-or DCA-induced HCT116 BAX-ko and HT29 cells undergoing autophagy ( Fig. 2A) . In addition, Pro-ChoPLs also enclosed and localized to vesicular structures that are likely to be autophagic vesicles ( Fig. 2A) .
The corrected total cell fluorescence (CTCF) measurements of Pro-ChoPLs were higher in the drug-induced autophagic cells when compared to their respective controls ( Fig. 2B) . These values were in a good agreement with the fold increases in ChoPLs measured by 1 H-MRS (for HT29 cells) and 13 C-MRS (for HCT116 BAX-ko cells) ( Fig. 2B) .
The fold increases in CTCF are mostly likely reflecting the increases in PtdCho levels [34] , as it is the most abundant class of choline phospholipid (about 80% of all ChoPLs) present in mammalian cell membranes.
To determine the precise localization of the newly synthesized ChoPLs in druginduced autophagy, HCT116 BAX-ko cells were labeled with Pro-Cho as above and the position of Pro-ChoPLs was detected using immunogold labeling and imaging by transmission electron microscopy. Gold particles were localized to the nuclear envelope, the ER, mitochondria, plasma membrane and small vesicular structures in control cells, whereas the nucleus and areas of cytosol without membrane structures were largely devoid of gold label ( Fig. 3 ). More gold label was observed in both PI-103 and DCA-treated cells when compared to controls and they were visible on the membranes of autophagic vacuoles, as well as in digested material inside the autolysosomes ( Fig. 3) . Furthermore, we also observed electron-dense round structures with gold-labeled Pro-ChoPLs, consistent with lipid droplets, in close proximity to or inside autophagosomes ( Fig. 3) . These may reflect lipophagy and/or the transfer of Pro-ChoPLs between the lipid droplets and the autophagic structures [22, 35] . We concluded that the newly synthesized ChoPLs contribute to the phagophore and, subsequently, autolysosomal membranes.
Fluorescence signals from the newly synthesized choline phospholipids colocalized with mCherry-LC3 in pMAFs (pancreatic mouse adult fibroblasts) undergoing druginduced autophagy.
To further corroborate the colocalization of the newly synthesized ChoPLs with autophagosomes, pMAFs expressing mCherry-GFP-LC3 were labeled with Pro-Cho, and the degree of colocalization of Pro-ChoPLs with LC3 was detected using confocal microscopy.
Increased mCherry-LC3 signal was found in pMAFs cells treated with bafilomycin A1, Torin-1 or PI-103 when compared with dimethyl sulfoxide (DMSO) control, confirming the induction of autophagy and autophagosome accumulation ( Fig. S3A) . No green fluorescence signal was observed for GFP, due to the steps in the click chemistry reaction that involve a very low pH which led to the quenching of GFP signal. Hence, only red florescence signals from mCherry-LC3 were observed ( Fig. S3A) . In order to confirm the specificity of the Pro-Cho fluorescence probe, a negative control was utilized in which click chemistry was performed on pMAFs cells using the Alexa Fluor 350-azide probe without prior incubation with Pro-Cho. No signal from the Alexa Fluor 350-azide probe was observed ( Fig. S3A) . This experiment confirmed the specificity of the Alexa Fluor 350 probe and the absence of its interference with the mCherry signal.
Pro-ChoPL signal intensities were found to increase in cells treated with bafilomycin A1, Torin-1 or PI-103 when compared to the DMSO-treated control (Fig. S3B) . The labeled
Pro-ChoPLs (blue) signals were pseudo-colored to green using the Zeiss software on the microscope, in order to enhance the contrast against the red signal ( Figs. 4A and S3B ).
Significant increase in the colocalization of Pro-ChoPLs and mCherry-LC3 signals was also found in treated cells when compared with DMSO control ( Fig. 4 and S3B) , confirming the colocalization of the Pro-ChoPLs and the mCherry-LC3 signals upon treatment with autophagy-modulating drugs. We concluded that the colocalization of the signals from the newly synthesized Pro-ChoPLs and mCherry-LC3 increased significantly following autophagy induction and the autophagosome accumulation.
Increased expression of the active membrane-bound form of PCYT1A was associated with increased ChoPLs synthesis in autophagic cells.
To determine the mechanisms responsible for the observed reduction in PCho and increase in PtdCho during autophagy, we examined the expression level of the main isoform of choline kinase -CHKA (choline kinase alpha), the first enzyme in the Kennedy pathway of PtdCho synthesis. The expression of CHKA was reduced in both HCT116 BAX-ko and HT29 cells treated with PI-103 for 24 h, but unchanged in 24 h DCA-treated and 6 h starved HCT116 BAX-ko cells (Fig. 5A) . These findings were consistent with previous reports of reduced PCho levels and reduced choline kinase expression in PI-103-treated cancer cells [36, 37] .
To examine how the reduction of CHKA protein level with PI-103 treatment affects the rate of PCho synthesis, choline kinase activity was assayed in HCT116 BAX-ko cell lysates using 31 P-MRS after the addition of exogenous choline, ATP and MgCl2 ( Fig. 5B) .
Choline kinase activity was lower (58±6%, p=0.002) in lysates of HCT116 BAX-ko cells treated with PI-103 for 24 h (0.86±0.06 nmol min -1 per 10 6 cells) when compared with vehicle-treated controls (1.50±0.07 nmol min -1 per 10 6 cells) ( Fig. 5C) , which was consistent with the decreased PCho level in PI-103-treated cells ( Fig. 1D) . Increased de novo ChoPL synthesis was found in cells with active autophagy, despite decreases in PCho and CHKA expression and activity. Hence, our data suggested that the observed increase of ChoPLs in cells undergoing drug-induced autophagy was not dependent on CHKA expression or activity, consistent with it not being rate-limiting in the biosynthesis of PtdCho, the most abundant ChoPL species [38] .
The rate-limiting enzyme in the PtdCho biosynthesis pathway, PCYT, catalyzes the production of CDP-choline from cytidine-5'-triphosphate (CTP) and PCho [38] . We saw increased expression of the main isoform of PCYT, PCYT1A, in all our treatment groups when compared to controls ( Fig. 5D and S4A) . The main isoform, PCYT1A, becomes activated when the inactive cytosolic form associates with cellular membranes [39] . When the membrane fraction of PCYT1A was isolated from the cytosolic fraction using digitonin permeabilization [40] , an increase in the expression of the active, membrane-bound form of PCYT1A was seen in all of our autophagy models ( Fig. S4B) . These data indicate that higher levels of PCYT1A in its activated form are expressed in autophagic cells.
Loss of PCYT1A activity abrogated autophagy.
To study the cellular effect of ChoPLs and PCYT1A activity on the autophagy process, we used the Chinese hamster ovary (Cho)-derived MT58 cell line, which contains a temperature-sensitive inactivating mutation in PCYT1A [41] . The wild-type CHO-K1 cells have the same PCYT1A activity at both 33°C and 40°C, whereas raising the temperature from 33°C to 40°C causes the loss of PCYT1A protein stability and function in CHO MT58 cells, allowing us to examine the effect of acute loss of PCYT1A on the autophagy process ( Fig. 6A) . There was no difference in the 4 d GI50 for PI-103 between the two cell lines (MT58: 270±30 nM; CHO-K1: 290±20 nM). MT58 and wild-type CHO-K1 cells were treated for 24 h with 11.4 μM PI-103 to achieve ca. 70% reduction in cell number when compared to control cells at 33°C, and ca. 50% reduction at 40°C. The increased level of LC3B-II confirmed the induction of autophagy in both cell lines with PI-103 treatment at both 33°C and 40°C (Fig. 6B) . The elevated autophagy marker LC3B-II in vehicle-treated MT58 cells at 40°C is likely to be a stress response to the loss of PCYT1A activity ( Fig. 6B) . Unlike the CHO-K1 cells, MT58 cells did not have increased LC3B-II levels with PI-103 treatment at 40°C when compared to 33°C ( Fig. 6B) .
Both CHO-K1 and MT58 cells had an increased level of ChoPLs after the 24 h treatment with PI-103 compared to control at the permissive temperature of 33°C ( Fig.   6C ). However, at the restrictive temperature of 40°C, the vehicle-treated MT58 cells had a reduced level of ChoPLs that was not increased upon PI-103 treatment ( Fig. 6C) . Consistent with the inhibition of PCYT1A activity at 40°C, vehicle-treated MT58 cells at 40°C had a build-up of PCho, the substrate of PCYT1A, in agreement with previous findings [41] (Fig.   6D ). 
Pro
Electron microscopy was performed on CHO-K1 and MT58 cells following 18 h and 24
h of vehicle and PI-103 treatment at 33°C and 40°C to investigate the dynamics of autophagosome formation. Following 18 h of PI-103 treatment, autophagic vacuoles were present in both CHOK-1 and MT58 cells at 33°C and 40°C, indicating that autophagy could be initiated even when PtdCho synthesis by PCYT1A was impaired ( Fig. 7A) . However, the proportion of cytosolic area occupied by autophagic vacuoles was reduced in MT58 cells at the restrictive temperature at this time-point ( Fig. 7A and B) . After 24 h of PI-103 treatment, the area of cytosol occupied by autophagic vacuoles increased in all PI-103-treated samples, with the exception of the PI-103-treated MT58 cells at 40°C, which had very few autophagic vacuoles present ( Fig. 7A and B) . We concluded that the loss of PCYT1A activity resulted in the inability of cells to sustain autophagosome formation during prolonged periods of autophagy. Consistent with this, even though the levels of LC3B-II were slightly increased in vehicle-treated MT58 cells at 40°C, there were no autophagosomes or autophagic vacuoles visible under this condition (Fig. 7A) .
The loss of PCYT1A activity also resulted in the dilation of the ER and appearance of spherical ER structures in both vehicle-and PI-103-treated MT58 cells at 40°C, consistent with a previous report [42] . We observed that the loss of PCYT1A activity also caused alterations in mitochondrial morphology, with the shape of mitochondria becoming more rounded, with no apparent deformations of mitochondrial cristae (Fig. 7A) . Thus, the impairments of PtdCho synthesis resulted in disruption of normal ER and mitochondrial appearance.
Phospholipid architecture was altered in autophagy.
To further characterize the PtdCho and related species that were increased during autophagy, we performed targeted metabolomic analysis using the Absolute IDQ p180 kit to measure the levels of 101 choline-containing phospholipid species in the four choline phospholipid groups: PtdCho ester phospholipids (35) , PtdCho ether phospholipids (38) , LysoPtdChos (14) and SMs (14) . To ensure that the observed changes in phospholipid species were related to autophagy rather than to the more general drug effects, Tat-Beclin 1 peptide-induced autophagy models were added to the analysis (Fig. 8A) .
In all the autophagy models, for both HCT116 WT and HCT116 BAX-ko cell lines, there were increased levels of both ester PtdChos and ether PtdChos (plasmalogens) with longer fatty acid/alcohol chain length (with a total of 36-40 carbon atoms per PtdCho molecule) and higher chain unsaturation (3-6 double bonds per PtdCho molecule) (Fig. 8B) . The total of all LysoPtdChos and SMs measured also increased in all treatment-induced and Tat-Beclin 1-induced autophagic cells, indicating the involvement of additional pathways of choline phospholipid metabolism. These data suggested that the de novo PtdCho synthesis might be important not only to increase the absolute amounts of PtdCho but also to alter the ChoPL profile for the autophagosome and autolysosome membrane formation. These findings are in keeping with the work of Dupont et al., who showed that lipid droplets are mobilized for use in autophagosome membrane synthesis during starvation, which may avoid the use of preformed membranes for autophagy [22] . In addition, they showed that knockdown of CHPT1 (choline phosphotransferase 1), the last enzyme of the [43, 44] . Given the known role of PtdEth in initiation of autophagosome formation, sensing of membrane stress in phagophores, as well as in other organelles from which membrane lipids are delivered to the growing phagophore, by PCYT1A, could provide a mechanism for linking PtdCho synthesis to the autophagy process.
Discussion
We also found increased levels [48] . SCD is also important for cancer cell survival in metabolically compromised environments [49] . Further studies of the fatty acyl chain requirements for the dynamic membrane processes that take place during autophagy and the enzymes involved in membrane lipid remodeling could provide novel targets to interfere with autophagy.
Another choline phospholipid species that was significantly increased was SM.
Sphingolipids have signaling roles in autophagy [50] , but Yamagata et al. provided evidence that autophagosome formation in starved yeast requires inositol phosphorylceramide, a sphingolipid structurally similar to the mammalian SM [51] . Excess SM that occurs in SMPD1 (sphingomyelin phosphodiesterase 1, acid lysosomal)-deficiency (Niemann-Pick diseases) prevents autophagosome closure by defective regulation of ATG9 (autophagy related 9) cycling during autophagosome maturation [52] . The role of SM in mammalian autophagosome formation requires future investigation.
The findings presented here are also congruent with bioenergetic considerations: it has long been established that autophagosomal membranes, unlike those of other organelles, are largely devoid of protein [53] . It is energetically more costly to remove proteins from existing membranes than to synthesize new membranes, supporting the finding that autophagosome membranes are synthesized de novo [15] . Our work suggests 
Materials and Methods
Cell culture and treatment.
All media and reagents for cell culture were purchased from Life Technologies.
HCT116 BAX-ko and HCT116 WT cells were a kind gift of Dr Bert Vogelstein, Johns 
mCherry-GFP-LC3 pancreatic mouse adult fibroblast cells.
pMAFs were derived from mCherry-GFP-LC3 homozygous mice (kindly provided by Ian Ganley, The University of Dundee). After aseptic dissection, the pancreas was finely minced and digested in a 'liberase blendzyme' (Roche, 05401020001) for 60 min at 37°C.
Tissue fragments were then plated onto 10-cm culture dishes and allowed to attach.
Fibroblasts were seen to 'crawl' out of the tissue for up to 10 d. These fibroblasts were harvested and sub-cultured in RPMI 1640 medium (GlutaMAX supplemented, Life
Technologies, 72400021) with 10% FCS, 50 µM of 2-mercaptoethanol (Sigma Aldrich, M6250) and 50 µM of asparagine (Sigma Aldrich, A4159). The fibroblasts divide rapidly for a few divisions, then slow down and cell numbers remain constant or decline slightly for up to 6-8 weeks. Following on from this 'crisis' the cells once again return to fast replication at which point they are considered immortal and suitable for use in ongoing studies.
Immunoblotting.
Western blotting was performed as described previously [28] . Protein densitometry was performed using ImageJ v1.48 (NIH) software. Relative optical density was calculated by dividing the densitometry of protein with its respective loading control from the same blot. The values obtained were used to calculate the treatment:control ratios.
CHK activity assay.
CHK activity was assayed using an MRS-based method as described [55] μl. 31 P NMR spectra were acquired using a 30° proton-decoupled pulse sequence, spectral width of 12,000 Hz, 1.65 s relaxation delay and 128 scans per FID on a Bruker 500 MHz spectrometer (Bruker Biospin, Coventry, UK). Line broadening of 5 Hz was applied before Fourier transformation and the peak areas were integrated. The absolute concentrations of metabolites were determined using the ATP at the start of the experiment as a reference.
The CHK activities were calculated from the straight-line fit to plots of PCho versus time and normalized to cell number.
H-MRS of cell extracts.
For cellular metabolite analysis, water-soluble and lipid metabolites were extracted using a dual phase extraction protocol [56] . 
MRS measurements.
All spectra were acquired on a 500 MHz spectrometer (Bruker Biospin, Coventry, UK) at 298 K. 1 H spectra were acquired with 7,500 Hz spectral width, 32,768 time domain points, relaxation delay of 2.7 s and 128 or 256 scans for lipid or water-soluble cell extracts, respectively. The water resonance from soluble cell extract samples was suppressed by a gated irradiation centered on the water frequency. For 13 C-MRS 13,000 spectral averages were acquired for with 26,000 Hz spectral width, 32,768 time domain points and 6.5 s relaxation delay. The spectra were phased and manually baselinecorrected using Bruker TopSpin-3.1 (Bruker Biospin) and MestRe-C-4.9.9.6 6 (Mestrelab Research) software packages, respectively. Spectral assignments were based on literature values [56] [57] [58] . Metabolite levels were standardized to cell number.
Targeted metabolomics analysis.
Extracted intracellular metabolites were measured using AbsoluteIDQ ® p180 targeted metabolomics kit according to manufacturer's instructions (Biocrates Life Sciences AG, Innsbruck, Austria). The cells were lysed in 1.5 ml ice-cold 85% ethanol, scraped into 2 ml microcentrifuge tubes and subjected to three rounds of sonication followed by rapid freeze-thaw. The lysates were sonicated for 15 s, frozen for 30 s in liquid nitrogen, rapidly thawed in a 98°C water bath and returned to ice. After the third round of freeze-thaw cycle, the cell lysates were centrifuged at 16,000 g for 10 min at 4°C, and the supernatants were collected and freeze-dried to avoid hydrolysis of unstable metabolites.
The lyophilized metabolites were stored at -80°C until analysis. The freeze-dried powder was then resuspended in 85% ethanol and 15% of 10 mM phosphate buffer, pH 7.4 to achieve cell concentration of 40 million cells/ml. 10 μl of the sample was applied to the AbsoluteIDQ ® p180 plate.
Mass spectrometry data acquisition and processing.
For quantification of glycerophospholipids and sphingolipids, metabolite measurements were performed using the validated AbsoluteIDQ p180 targeted metabolomics kit (Biocrates Life Sciences AG). The samples were processed in the 96-well format provided as per the instructions of the manufacturer. The sample preparations were injected directly into a Waters Xevo TQ-S mass spectrometer coupled to an Acquity 
Propargyl-choline synthesis.
Propargyl-choline (Pro-Cho) was synthesized using the method described [34] .
Briefly, dimethylethanolamine (3.54 ml, 35.3 mmol; Sigma Aldrich, 38990) was added to a solution of propargyl bromide (80% in toluene, 3.74 ml, 33.6 mmol; Sigma Aldrich, 81831) in anhydrous tetrahydrofuran (THF; 10 ml; VWR, 44608.AE) at 0°C under a nitrogen atmosphere. The solution was allowed to warm to room temperature and was stirred for 18 h, after which time the resultant solid was washed with cold THF (3 x 20 ml) and dried in vacuo to afford the title compound as an off-white solid (6.05 g, 87% yield). 
Pro-Cho labeling of cells and detection by confocal fluorescence microscopy.
Pro-Cho labeling was performed as described [34] . In essence, HCT116 BAX-ko and 
Immuno-gold electron microscopy of Pro-Cho-labeled cells.
HCT116 BAX-ko cells were treated with 1 mM Pro-Cho and PI-103 or DCA as for confocal microscopy. The cells were washed with PBS, detached from the dish in 0.5 mM EDTA in PBS, pelleted and fixed with 4% formaldehyde (prepared from a 16% stock; TAAB, 
Quantitative colocalization analysis.
Samples were viewed on a Zeiss LSM700 confocal microscope at x63 magnification.
Colocalization was measured using the Zen 2009 software (Carl Zeiss). Colocalization was performed on a pixel by pixel basis with every pixel in the image plotted onto a scatter diagram. Segmentation was established by using the software to false color the red and green pixels (as single color staining was not possible), so that the placement of the crosshairs can be estimated. Quadrant 3 on the scatterplot shows the colocalized pixels.
The colocalized pixels in the images were false colored to white, so that the location of these pixels could be observed more readily. Once these conditions were established, they were subsequently kept constant throughout the analysis. Region of interest (ROI) were drawn around each cell in each field of view, in order to remove the areas of no signal which can skew the results. Colocalization was quantified using the Manders colocalization coefficient, as this is sensitive to colocalization independent of a linear relationship of signal levels to each other [59, 60] . Colocalization coefficient ch1-T1 and colocalization coefficient ch2-T2 were analyzed. The colocalization coefficients describe the contribution of each one from two selected channels to the pixels of interest, i.e, the colocalization coefficient ch1-T1 shows the value of how many red pixels colocalize with the green pixels, whereas, the colocalization coefficient ch2-T2 shows the value of how many green pixels colocalize with the red pixels. The values are between 0 and 1 where 1 corresponds to 100% colocalization, 0.2 to 20% and 0 to no colocalization [61] . 
Electron microscopy of CHO-K1 and MT58 cells
Statistics.
All assays were performed at least in triplicate and data presented as mean ± 1 SEM. 
Figure Legends
